|
|
 |
. 50 120 / 1 .
Glaxo Wellcome
|
|
|
 |
. /. 0,5 2 / 10 .
GlaxoSmithKline Australia
|
|
|
 |
/. . 500 /1 (60 ) / 1 .
Glaxo Wellcome
|
50919 tenge
|
|
 |
|
|
|
 |
/. . 250 /1 (120 ) / 1 .
Glaxo Wellcome
|
52745 tenge
|
|
|
|
|
|
 |
: . 15 / 1 .
Ursapharm
|
|
|
 |
. . / . - 600 / 10 .
Zambon Group
|
|
|
 |
- /. 10 % . 3 / 5 .
Zambon Group
|
|
|
 |
. / - /. . 200 1 / 20 .
Zambon Group
|
|
|
 |
. /., . . 250 , / 60 .
Adamed
|
24185 tenge
|
|
|
|
|
|
 |
/., . . 125 / 60 .
Pabianice pharmaceutical works Polfa
|
20129 tenge
|
|
|
|
|
|
|
|
